|Prof. Michael Barry MB, FRCPI, PhD
Prof. Michael Barry is a Consultant Clinical Pharmacologist and Head of the Department of Pharmacology & Therapeutics at the University of Dublin, Trinity College. He is the clinical director of the National Centre for Pharmacoeconomics which conducts pharmacoeconomic evaluations on medicines prior to reimbursement under the Community Drugs schemes in Ireland. He is Past-President (2010-2011) of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He was a board member of the Health Information and Quality Authority (HIQA) and is a member of a number of National Committees on pricing and reimbursement of medicines. Prof. Barry chairs the New Drugs Committee and the Medication Safety Committee at St. James’s Hospital, Dublin. In 2013 he was appointed as Clinical Lead for the new HSE Medicines Management Programme. He is a fellow of the Royal College of Physicians in Ireland and is a specialty trainer for Pharmacology & Therapeutics. His research areas include the cost-effectiveness of high cost drugs including chemotherapeutic agents and biologic drugs, pricing and reimbursement and performance based risk sharing schemes. He has published widely on the cost-effectiveness of medicines in the Irish healthcare setting.
|Deputy Head of NCPE:|
|Dr. Lesley Tilson BSc (Hons) Pharm, PhD
Dr. Lesley Tilson is Chief I Pharmacist at the National Centre for Pharmacoeconomics and is a graduate of the University of Brighton. She trained in the Chelsea and Westminster hospital, London and then worked as a resident pharmacist at the Oxford Radcliffe Hospitals NHS Trust. During this time she completed a Diploma in Clinical Pharmacy with Cardiff University. Lesley worked as a senior clinical pharmacist at St James’s Hospital Dublin, on the intensive care unit and cardiac surgery ward. She has a PhD from the Department of Pharmacology and Therapeutics, Trinity College Dublin (2002-2005) and a Diploma in Statistics from Trinity College Dublin (2003-2004). She is a lecturer in pharmacoeconomics to undergraduate and postgraduate pharmacy students. Research interests include: Economic evaluation of pharmaceuticals in the Irish setting, pharmaceutical pricing and reimbursement strategies, policies to promote generic markets, international pharmaceutical pricing, analysis of drug utilisation and expenditure trends. She received the ISPOR Bernie O’Brien New Investigator Award in May 2011.
|Current staff include:|
|Dr. Roisin Adams, MPharm, MSc., PhD
Roisin Adams is currently on secondment from her position as Deputy Head of the National Centre for Pharmacoeconomics, to the HSE National Drugs Management Programme. She has over 20 years experience in clinical pharmacy and undertook her PhD on the cost effectiveness of biologic agents in inflammatory rheumatolgical disease. She is a graduate of the Robert Gordon University, Aberdeen and trained in Ninewells Hospital, Dundee. In 2003 she was appointed Chief II pharmacist in St. James’s Hospital where she specialised in palliative care and rheumatology. Dr. Adams completed her MSc. in Clinical Pharmacy at Queens University, Belfast. She is a member of the review group for pharmaceutical technologies at the NCPE since 2008. Her areas of interests include utility measurement, methodology of indirect comparisons for evidence synthesis and methods for stakeholder input into health technology assessment. She undertook the first national study to measure people in Ireland’s preferences for health and is a HRB principal investigator on a study examining patients’ preferences for health.
Email: email@example.com; firstname.lastname@example.org
|Prof. Kathleen Bennett BSc, PhD (Statistics)
Professor Kathleen Bennett is Associate Professor in Biostatistics at the RCSI (Royal College of Surgeons in Ireland) Division of Population Health Sciences, and a Health Research Board (HRB) Research Leader. Professor Bennett leads a research team undertaking a programme of research titled “Statistical epidemiology in Population Health and Health Services Research: Quality and Patient Safety in Medicines”. Professor Bennett has over 25 years’ experience of undertaking medical research. After completing her BSc in mathematics and statistics at Southampton University, UK she spent 2 years working as a clinical trials statistician in the Pharmaceutical Industry before returning to Southampton to complete a PhD. She was employed as an epidemiologist/statistician in the Department of Pharmacology and Therapeutics, Trinity College Dublin for many years and retains a part-time position in the Department. Professor Bennett is an advisor to the National Centre for Pharmacoeconomics on pharmacoepidemiology and statistics.
|Dr. Emer Fogarty BSc Pharm, Dip (Stat), MSc, PhD
Emer Fogarty is acting Chief II Pharmacist and a member of the economic review group at the National Centre for Pharmacoeconomics. She graduated from Trinity College, Dublin in 2004 and completed an MSc in Clinical Pharmacy with University College, Cork. Formerly employed as a clinical pharmacist in St. James’s Hospital, Emer worked in numerous clinical pharmacy specialities including general medicine, oncology, and infectious diseases. She completed a PhD examining the cost-effectiveness of treatments for multiple sclerosis, and her research interests are comparative effectiveness and health economic modelling.
Niamh is a Grade IV Clerical Officer at the National Centre for Pharmacoeconomics. She completed a computer/receptionist course in Crumlin College of Business and Technical studies in 1989. Prior to starting in St. James’s Hospital in 1996 Niamh had been working for a private orthodontist for six years. Since joining St. James’s Hospital she has worked in various different departments including the Central Pathology Laboratory and Personnel (Human Resources). She also spent time working with the National Medicines Information Centre before joining the National Centre for Pharmacoeconomics (NCPE) in 2000.Email: email@example.com
Claire Gorry is a graduate of the School of Pharmacy, Trinity College Dublin. She completed a community pharmacy pre-registration placement and has since gained experience in community, hospital and industry roles. Most recently she has worked as haematology/oncology clinical trials pharmacist in St James hospital. Claire has completed a post graduate diploma in Clinical Pharmacy from Queen’s University Belfast and a diploma in Health Economics from University College Dublin. Claire is currently undertaking a PhD in the NCPE, researching the cost effectiveness of treatments for metastatic melanoma.
|Dr. Jennifer Kieran
Dr Jennifer Kieran is currently a consultant in Clinical Pharmacology and Therapeutics in St. James Hospital, Dublin and an Adjunct Professor in Clinical Pharmacology and Therapeutics in Trinity College Dublin. She is a specialist in Infectious Diseases and General Internal Medicine and is undertaking a PhD in Pharmacoeconomics focussing on the cost-effectiveness of treatments for Hepatitis C virus in Ireland. She graduated from the Royal College of Surgeons in Ireland and underwent Higher Specialist Training in University College Hospital, Galway, Mater Misericordiae University Hospital, Dublin and St James Hospital, Dublin. She was awarded a Scholarship from the Infectious Diseases Society of Ireland and undertook a Fellowship in Microbiology in the Royal North Shore Hospital, Sydney. She has published in the areas of HIV medicine, HIV/HCV co-infection, outpatient antibiotic therapy and antimicrobial stewardship.
|Dr. Anne Marie Liddy
Dr Anne Marie Liddy is a Specialist Registrar in General Medicine and Clinical Pharmacology and an Assistant Professor within the Department of Pharmacology and Therapeutics, Trinity College Dublin. She was a scholar of Trinity College Dublin and graduated from medicine in 2010. She became a member of the Royal College of Physicians in 2012 and commenced her specialist training in Pharmacology in 2014. She is currently pursuing a PhD with a special interest in the pharmacokinetics, and was awarded the British Pharmacological Society GSK prize in Clinical Pharmacology for the presentation of this work in 2014. Dr Liddy is currently the National Specialist Trainee representative for Clinical Pharmacology in the RCPI and member of several committees in St James’s Hospital which oversee the use of medicines in clinical practice. She has a keen interest in academic medicine and is the recipient of the JS Prichard award for undergraduate medical education.
|Dr. Laura McCullagh BSc (Hons) Pharm, Dip., PhD
In January 2016, Laura was appointed to the post of Associate Professor of Pharmacoeconomics & Health Technology Assessment within the Department of Pharmacology & Therapeutics. She is a member of the National Centre for Pharmacoeconomics (NCPE) Review Group for economic evaluations. Previous roles have included a HRB Research Fellow within the Department of Pharmacology & Therapeutics, a Chief II in St James’s Hospital, Dublin and a Senior Medicines Information Pharmacist, Oxford Radcliffe Trust, Uk. Laura holds a PhD from the Department of Pharmacology & Therapeutics for her research which focused on Health Technology Assessment within the Irish Healthcare Setting. She is a graduate of the Sunderland School of Pharmacy. She completed her diploma in hospital pharmacy at De Monfort University, Leicester. Research interests include Pharmacoeconomic Evaluations, Value of Information Analysis and Survival Analysis.
|Helen O’Donnell BSc Pharm, MPharm, MSc (Health Economics)
Helen O’Donnell is a research pharmacist at the National Centre for Pharmacoeconomics. Helen is a graduate of Trinity College Dublin where she was elected a scholar. She completed her MPharm studies at the Royal College of Surgeons in Ireland. After qualifying as a pharmacist in 2012, Helen worked in community pharmacy before undertaking a Masters in Health Economics in National University of Ireland Galway. She is currently undertaking a PhD examining the cost-effectiveness of lipid lowering treatments in Ireland.
|Dr. Aisling O Leary BSc Pharm, PhD
Dr. O’Leary MPSI, a graduate of the School of Pharmacy, Dublin University, Trinity College with a Ph.D in pharmaceutical chemistry, is a Chief II pharmacist in the centre. Her background is predominantly in hospital pharmacy where she worked in a variety of clinical disciplines including GUIDE, endocrinology, rheumatology and dermatology. She co-ordinated the M.Sc. in Hospital Pharmacy from 1995 to 2005 under the auspices of TCD. She retains an academic teaching role with the School of Pharmacy, RCSI where she is Programme Director of Studies of the National Pharmacy Internship Programme. She is a member of the Irish Medication Safety Network, the Hospital Pharmacists Association of Ireland and the 2012 Hospital Pharmacy Assessment Group (PSI). Since 2005 she has been involved in the appraisal of the cost-effectiveness of new technologies for the centre.
|Dr. Susanne Schmitz Dipl.Math, PhD
Dr. Susanne Schmitz is an Assistant Professor in the department of Pharmacology and Therapeutics in Trinity College Dublin. She holds a PhD from the department of Statistics, Trinity College Dublin, for her research on Bayesian methods for evidence synthesis and decision making in Health Technology Assessments. Susanne graduated in Mathematics from RWTH Aachen University in Germany. Her research interests are Bayesian biostatistics, evidence synthesis, meta-analytical methods such as mixed treatment comparison models as well as the role of uncertainty in decision theory and multiple criteria decision analysis. She has worked on applications related to rheumatoid arthritis, multiple sclerosis, hepatitis C and rotavirus modelling
|Dr. Susan Spillane MPharm, Dip (Stat), PhD, MPSI
Dr Susan Spillane is a senior research pharmacist and member of the assessment team in the National Centre for Pharmacoeconomics. Susan gained her Bachelor of Pharmacy degree at University College Cork. She completed her MPharm studies at the Royal College of Surgeons in Ireland and spent a year employed in the pharmacy department of St James’s Hospital. Prior to joining the NCPE Susan completed her PhD in cancer pharmacoepidemiology (Trinity College Dublin), using national datasets to study the effects of metformin and aspirin exposure on colorectal cancer outcomes. She also holds a postgraduate diploma in statistics (Trinity College Dublin) and is an alumnus of the HRB Health Services Research Scholars (now SPHeRE) Programme. Susan has also worked as a post doctoral researcher for the HSE Medicines Management Programme. She has a particular interest in pharmacoepidemiologic and drug utilisation studies and is currently involved in work to examine the effects of pharmaceutical policy interventions.
|Dr. Cara Usher BSc, PhD
Dr. Cara Usher is Senior Research Fellow at the National Centre for Pharmacoeconomics. Dr. Cara Usher is Senior Research Fellow at the National Centre for Pharmacoeconomics. She holds a PhD (Pharmacology) from University College Dublin and a post-graduate diploma in Health Economics from the University of York. Overall her work has focused on evaluation of healthcare technologies, education about the evaluation process and examining the effects of reimbursement decisions through a national primary care prescription database. Her research interests include analysis of pharmaceutical policy interventions and their impact on prescribing in the community. She holds a new investigator award from the International society for pharmacoeconomics and outcomes research (ISPOR, 2008) and is a visiting research fellow at Trinity College Dublin.
|Prof. Cathal Walsh MA, PhD
Prof. Cathal Walsh is a Professor in Statistics at Trinity College Dublin and a HRB Research Leader in Health Decision Science. Specific areas in which he has used his expertise are in the modelling of heterogeneity using latent variable models and in combining evidence from multiple sources. He has held visiting appointments in Bayesian groups in Australia and the United States. He contributes to the statistical societies in the UK and Ireland and is currently a member of the Council of the Royal Statistical Society. He is a Statistical Editor for the Cochrane Collaboration and has served as Associate Editor for statistics journals. He is an advisor to the National Centre for Pharmacoeconomics on statistical methodology for Health Technology Assessment.